Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients

References

• Isaacson P. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139–147
   PubMed Web of Science ®Google Scholar
• Cavali F, Isaacson P G, Gascoyne R D, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001; 1: 241–258
   Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Isaacson P G, Muller-Hermelink H K, Piris M A, Berger F, Nathwani B N, Swerdlow S H, . Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours, E S Jaffe, N L Harris, H Stein, J W Vardiman, et al. IARC Press, LyonFrance 2001; 157–160
   Google Scholar
• Drillenburg P, van der Voort R, Koopman G, Dragosics B, van Krieken J H, Kluin P, et al. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol 1997; 150: 919–927
   PubMed Web of Science ®Google Scholar
• Dogan A, Du M, Koulis A, Briskin M J, Isaacson P G. Expression of lymphocyte homing receptors and vascular addressing in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997; 151: 1361–1369
   PubMed Web of Science ®Google Scholar
• Drillenburg P, Pals S T. Cell adhesion receptors in lymphoma dissemination. Blood 2000; 95: 1900–1910
   PubMed Web of Science ®Google Scholar
• Nathwani B N, Anderson J R, Armitage J O, Cavalli F, Diebold J, Drachenberg M R, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999; 17: 2486–2492
   PubMed Web of Science ®Google Scholar
• Isaacson P. Extranodal lymphomas: the MALT concept. Verh Dtsch Ges Pathol 1992; 76: 14–23
   PubMedGoogle Scholar
• Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96: 410–419
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Ortiz-Hidalgo C, Falzon M R, Isaacson P G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–1176
   PubMed Web of Science ®Google Scholar
• Du M Q, Isaccson P G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Doglioni C, Diss T C, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–577
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz M K, et al. International Extranodal Lymphoma Study Group. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489–2495
   PubMed Web of Science ®Google Scholar
• Raderer M, Wöhrer S, Streubel B, Troch M, Turetschek K, Jäger U, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 2006; 24: 3136–3141
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999; 17: 1254–1258
   PubMed Web of Science ®Google Scholar
• Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, et al. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. The Oncologist 2006; 11: 285–291
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15: 1624–1630
   PubMed Web of Science ®Google Scholar
• Streubel B, Simonitsch-Klupp I, Müllauer L, Lamprecht A, Huber D, Siebert R, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722–1766
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Kurtin P J, Myers J L, Adlakha H, Strickler J G, Lohse C, Pankratz V S, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surgical Pathol 2001; 25: 997–1008
   PubMed Web of Science ®Google Scholar
• Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A, Raderer M. Extranodal marginal zone B-cell lymphoma tissue of the head and neck area. Cancer 2003; 97: 2236–2241
   PubMed Web of Science ®Google Scholar
• Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol 1999; 83: 742–747
   PubMed Web of Science ®Google Scholar
• Servitje O, Gallardo F, Estrach T, Pujol R M, Blanco A, Fernandez-Sevilla A, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002; 147: 1147–1158
   PubMed Web of Science ®Google Scholar
• Isaacson P G, Banks P M, Best P V, McLure S P, Muller-Hermelink H K, Wyatt J I. Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol 1995; 19: 571–575
   PubMed Web of Science ®Google Scholar
• Parveen T, Navarro-Roman L, Medeiros L J, Raffeld M, Jaffe E S. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the kidney. Arch Pathol Lab Med 1993; 117: 780–783
   PubMed Web of Science ®Google Scholar
• Ansell S M, Grant C S, Habermann T M. Primary thyroid lymphoma. Semin Oncol 1999; 26: 316–323
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023–1033
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727–737
   PubMed Web of Science ®Google Scholar
• Hyjek E, Isaacson P. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988; 19: 1315–1326
   PubMed Web of Science ®Google Scholar
• Diss T C, Wotherspoon A C, Speight P, Pan L, Isaacson P G. B-cell monoclonality, Epstein Barr virus, and t(14;18) in myoepithelial sialadenitis and low grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol 1995; 19: 531–536
   PubMed Web of Science ®Google Scholar
• Ambrosetti A, Zanotti R, Pattaro C, Lenzi L, Chilosi M, Caramaschi P, et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjogren syndrome or hepatitis C virus infenction. Br J Haematol 2004; 126: 43–49
   PubMed Web of Science ®Google Scholar
• Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela J M, Soussi T, et al. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766–775
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586–594
   PubMed Web of Science ®Google Scholar
• Rosado M F, Byrne G E, Jr, Ding F, Fields K A, Ruiz P, Dubovy S R, et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006; 107: 467–472
   PubMed Web of Science ®Google Scholar
• Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457–461
   PubMed Web of Science ®Google Scholar
• Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E, et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263–268
   PubMed Web of Science ®Google Scholar
• Luppi M, Longo G, Ferrari M G, Ferrara L, Marasca R, Barozzi P, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94: 373–375
   PubMed Web of Science ®Google Scholar
• Ascoli V, Lo Coco F, Artini M, Levrero M, Martelli M, Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998; 109: 600–609
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Maggi-Solcà N, Conconi A, Bertoni F, Reilly I, et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147–153
   PubMed Web of Science ®Google Scholar
• Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239–248
   PubMed Web of Science ®Google Scholar
• Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000; 83: 454–457
   PubMed Web of Science ®Google Scholar
• de Boer J P, Hiddink R F, Raderer M, Antonini N, Aleman B MP, Boot H, et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica 2008; 93: 201–206
   PubMed Web of Science ®Google Scholar
• Thieblemont C. Clinical presentation and management of marginal zone lymphoma. Hematology (Am Soc Hematol Educ Program) 2005; 1: 307–313
   Google Scholar
• Ahmed S, Kussick S, Siddiqui A, Bhuiya T, Khan A, Sarewitz S, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004; 40: 1320–1326
   PubMed Web of Science ®Google Scholar
• Siakantaris M P, Gonis N K, Angelopoulou M K, Kourtis I, Kontopidou F N, Dimopoulou M N, et al. Low grade gastric MALT lymphoma (LGGMALT) clinical stage I. A seemingly localized disease. Blood 2000; 96: 329a, abstract #1420
   Web of Science ®Google Scholar
• Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005; 11: 3349–3352
   PubMed Web of Science ®Google Scholar
• Conconi A, Martinelli G, Thieblemont C, Ferreri A J, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741–2745
   PubMed Web of Science ®Google Scholar
• Kalpadakis C, Pangalis G A, Dimopoulou M, Vassilakopoulos T P, Kyrtsonis M C, Korkolopoulou P, et al. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Heamatol Oncol 2007; 25: 107–114
   PubMed Web of Science ®Google Scholar
• Kyrtsonis M, Siakantaris M P, Kalpadakis C, Dimopoulou M N, Vassilakopoulos T P, Kontopidou F N, et al. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab. Eur J Haematol 2006; 77: 300–303
   PubMed Web of Science ®Google Scholar
• Boussiotis V A, Panayiotidis P G, Pangalis G A. Prolonged intermittent chlorambucil administration in B-chronic lymphocytic leukemia: experience from a single haematology Unit. Leuk Lymphoma 1991; 5(Suppl)113–118
   Web of Science ®Google Scholar